Clene to Present at Upcoming May Conferences

SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis and multiple sclerosis, today announced that it will participate in the following investor conferences in May.

Mizuho Neuroscience Summit 2024Dates: May 20-21, 2024Location: Boston Harbor Hotel, Boston, MAFormat: Panel Presentations and 1x1 meetings

Benchmark 2024 Healthcare House Call Virtual ConferenceDates: May 21-22, 2024Location: VirtualFormat: 1x1 meetings

Virtual A.G.P. Healthcare ConferenceDate: May 22, 2024Location: VirtualFormat: 1x1 meetings

About CleneClene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on X (formerly Twitter) and LinkedIn.

Contacts:

Media Contact Ignacio Guerrero-Ros, Ph.D., or David SchullRusso Partners, LLC[email protected][email protected](858) 717-2310

Investor ContactKevin GardnerLifeSci Advisors[email protected]617-283-2856

Source: Clene Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• UID and AEG ID Combine to Expand Industrial RFID Solutions Across North America
• Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing
• InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)